Virtus Biotech ETF (BBP)

Assets	$135.49M
Expense Ratio	0.34%
PE Ratio	15.85
Forward PE	17.93
Shares Out	1.30M
Dividend	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	7,584
Open	102.73
Previous Close	101.97
Day's Range	102.73 - 104.12
52-Week Low	72.81
52-Week High	110.05
Beta	0.58
Holdings	68
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus Biotech ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSE Arca
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

27.02% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	5.75%
Verastem, Inc.	VSTM	3.08%
Omeros Corporation	OMER	2.73%
Iovance Biotherapeutics, Inc.	IOVA	2.69%
Halozyme Therapeutics, Inc.	HALO	2.44%
Kiniksa Pharmaceuticals International, plc	KNSA	2.30%
Xeris Biopharma Holdings, Inc.	XERS	2.04%
Rigel Pharmaceuticals, Inc.	RIGL	2.02%
Precigen, Inc.	PGEN	2.02%
Regeneron Pharmaceuticals, Inc.	REGN	1.96%

Performance

BBP had a total return of 38.71% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.33%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Nov 4, 2026

Data Sources Report a data error